Read the highlights of the most recent edition of our weekly R&D information product R&D Pipeline News. The Special Product or Technology Pipelines of R&D Pipeline News are available via subscription of R&D Pipeline News or as a single Competitor Analysis.

Volume 5, Issue 23: MEK Inhibitors

Target Pipeline:

• MEK Inhibitors

Company Pipeline:

• Bayer Schering Pharma (Germany) NCE Pipeline
• Versartis (US)

More Details inside R&D Pipeline News
Get your annual subscription and receive this issue for free!

R&D Pipeline News

Get your Subscription Now

R&D Pipeline News is a premier information source about research and development (R&D) projects in the pipeline of the biopharmaceutical industry and is directed to all stakeholders in R&D . R&D Pipeline News covers all relevant treatment modalities, including. drugs, medical devices, biomaterials, combination products, cell therapy and drug delivery products.

• The Technology Edition lists the News in groups according to the product category, e.g. antibodies or vaccines etc. The product is delivered every week as a PDF directly to your desktop via e-mail.
• The Therapeutic Area Edition lists the News in groups according to the Therapautic Area, e.g. oncology, neurology, etc

---